Discover
CRT
Cross Timbers Royalty Trust
12.75
100 x undefined
100 x undefined
bid
ask
-
0.23
1.77%
100 @ 04:00 PM
12.75 +0.00 (0.00%)
| Ytd | 60.38% | |
| 1y | 63.46% |
12.38
day range
12.80
7.07
52 week range
13.15
| Open | 12.89 | Prev Close | 12.98 | Low | 12.38 | High | 12.80 | Mkt Cap | 76.50M |
| Vol | 25.03K | Avg Vol | 22.63K | EPS | 0.53 | P/E | 24.06 | Forward P/E | N/A |
| Beta | 0.54 | Short Ratio | 0.45 | Inst. Own | 2.63% | Dividend | 1.08 | Div Yield | 10.81 |
| Ex Div Date | 10-31 | Earning | 08-15 | 50-d Avg | 10.49 | 200-d Avg | 9.71 | 1yr Est | 0.00 |
CRT News
prnewswire.com
CROSS TIMBERS ROYALTY TRUST DECLARES SEPTEMBER CASH DISTRIBUTION
DALLAS, Sept. 18, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty
gurufocus.com
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedot
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the Europea
gurufocus.com
Innate Pharma Reports First Half 2026 Business Update and Financial Results
Regulatory News:Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (âInnateâ or the âCompany